COMMITTED TO MAKING A DIFFERENCE
Novavax, Inc. is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Our mission
We never rest in our quest to protect the health of people everywhere.
Novavax is here to make a difference. We're a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.
Our commitment is backed by solid science tested by decades of research, vaccines developed from trusted technology and a global network that will help to ensure our vaccines reach everyone who needs them.
Novavax APAC
Novavax's APAC Commercial Operations is based in Singapore.
Our Australia presence is located in Sydney, Australia, and together with New Zealand, we operate under a partnership with Biocelect. We also maintain strategic partnerships in the region with Serum Institute in India, SK bioscience in South Korea, and Takeda in Japan.
Novavax Europe
Starting 2022, Novavax started to develop commercial hubs throughout Europe with the regional main office in Zurich, Switzerland. Additonal offices are now established also in Brussels, Belgium and Barcelona, Spain. Local manufacturing facilities are in Czech Republic and Sweden.
09:00 - 17:00
Monday - Friday
More information is available on our global website, novavax.com.
Our location:
Novavax, Inc.
21 Firstfield Road
Gaithersburg, MD 20878
Email: [email protected]
Phone: +41 44 553 05 71
To contact a member of the investor relations team, click on the "Contact us" button below.